AZ12672857

AZ12672857是具有口服活性的EphB4(IC50=1.3nM)和Src激酶的抑制剂。AZ12672857抑制c-Src转染3T3细胞的增殖(IC50=2nM)和抑制转染CHO-K1细胞中的EphB4自磷酸化(IC50=9nM)。

此产品仅用于科学研究，我们不为任何个人用途提供产品和服务

库存: 现货

可选规格

包装

价格

促销价

数量
5mg

￥4312.00

3450.00

- +
10mg

￥7337.00

5870.00

- +
25mg

￥14425.00

11540.00

- +
50mg

￥23512.00

18810.00

- +
100mg

￥36337.00

29070.00

- +

已选 0 种 0 瓶

金额: ￥0.00

首页收藏

Background

AZ12672857 is an orally active inhibitor of EphB4 (IC50=1.3 nM) and Src kinases. AZ12672857 shows good inhibition of proliferation of c-Src transfected 3T3 cells (IC50=2 nM) as well as autophosphorylation of EphB4 in transfected CHO-K1 cells (IC50=9 nM)[1].

AZ12672857 shows only modest inhibition of CYP P450 (IC50=5 μM against 2C9 and 3A4, >10 μM against 1A4, 2D6 and 2C19). AZ12672857 inhibits p-KDR in HUVEC with an IC50 of 240 nM and inhibits p-PDGFR-βin MG63 cell line with an IC50 of 58 nM[1].

[1]. Bardelle C, et al. Inhibitors of the tyrosine kinase EphB4. Part 3: identification of non-benzodioxole-based kinase inhibitors. Bioorg Med Chem Lett. 2010;20(21):6242-6245.